Hepatoprotective and antifibrotic activity of watercress extract in a model of CCl4-induced liver fibrosis in Wistar rats
Article
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
The present study aimed to analyze the antioxidant and hepatoprotective efficacy of watercress extract against liver fibrosis induced by CCl4 (0.8 mL/kg, i.p) in an in vivo rat model. Four groups were included, each with five animals (n =5): 1) Intact, 2) CCl4-induced for 4 weeks, 3) CCl4-induced for 8 weeks, and 4) CCl4-induced for 4 weeks followed by watercress extract treatment (600 mg/kg/day) until week 8. Tissue samples were analyzed using histological techniques (H&E, Sirius Red, Masson’s trichrome stain), biochemical methods, and gene expression analysis of IL-1, IL-10, TGF-β, NRF2, Keap1, Acta2, Timp-2, MMP-13, and MMP-9. Watercress extract administration resulted in improvements by preventing steatosis and fibrosis. It also increased IL-10 expression in the liver and intestine. Additionally, the expression of fibrogenic markers such as TGF-β, Col 1α, Acta2, and Timp-2 was regulated. These results suggest that orally administered watercress extract prevents the progression of liver fibrosis.